← Open Payments lookup

KELLSEY SENN: Open Payments

NPI 1407488893 · LEXINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$612 in 27 payments from 13 companies in 2025. Trend: 2023 $75 · 2024 $238 · 2025 $612

Food & beverage: $612
CompanyPaymentsAmount
GENZYME CORPORATION4$131
GlaxoSmithKline, LLC.4$85
AstraZeneca Pharmaceuticals LP4$76
Genentech USA, Inc.2$63
Takeda Pharmaceuticals U.S.A., Inc.2$52
Optinose US, Inc.3$48
Galderma Laboratories, L.P.2$37
Pharming Healthcare, Inc.1$29
BioCryst US Sales Co., LLC1$28
Amgen Inc.1$19

Products named: DUPIXENT, TEZSPIRE, NUCALA, Xolair, CUVITRU, Xhance, NEMLUVIO, RUCONEST.

Industry payments across SC — which companies pay providers there.